Primary graft dysfunction after lung transplantation: Medium and long term outcomes

Letizia Corinna Morlacchi (Milan, Italy), Valeria Rossetti, Letizia Corinna Morlacchi, Maria Pappalettera, Paolo Tarsia, Alessandro Palleschi, Mario Nosotti, Francesco Blasi

Source: International Congress 2015 – Outcomes of lung transplantation
Session: Outcomes of lung transplantation
Session type: Poster Discussion
Number: 4542

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Letizia Corinna Morlacchi (Milan, Italy), Valeria Rossetti, Letizia Corinna Morlacchi, Maria Pappalettera, Paolo Tarsia, Alessandro Palleschi, Mario Nosotti, Francesco Blasi. Primary graft dysfunction after lung transplantation: Medium and long term outcomes. Eur Respir J 2015; 46: Suppl. 59, 4542

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pirfenidone stabilizes pulmonary function and reduces 18F-FDG-uptake in restrictive allograft syndrome following lung transplantation
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014

Assessment of the restrictive allograft syndrome in patients after lung transplantation
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012

Azathioprine discontinuation and medium and long term outcomes after lung transplantation
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015


Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD)
Source: International Congress 2018 – Rare lung diseases
Year: 2018


Risk factors for chronic lung allograft dysfunction (CLAD) in the SysCLAD cohort
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015

Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016


Chronic respiratory complications in paediatric heart transplant recipients
Source: Eur Respir J 2006; 28: Suppl. 50, 311s
Year: 2006

Lung transplantation in patients with ventilator-dependent respiratory failure
Source: Eur Respir J 2002; 20: Suppl. 38, 346s
Year: 2002

A new biomarker for chronic lung allograft dysfunction
Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes
Year: 2014

Orthotopic lung transplantation in a single-mismatch-based mouse model shows signs of chronic lung allograft dyfunction (CLAD)
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Anastomotic airway complications after lung transplantation: Risk factors, treatment modalities and outcome: A single center experience
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014

Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013

Oto score and medium-term outcomes in lung transplantation
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Pulmonary function and respiratory complications in hematopoietic cell transplant
Source: International Congress 2016 – Quality and quantity in lung function
Year: 2016


Cell therapy for the treatment of acute lung injury: Alveolar type II cells or mesenchymal stem cells?
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016

Lung transplantation: the ideal treatment for diffuse disease?
Source: Annual Congress 2006 - Up to date management of bronchiectasis
Year: 2006


Initial treatment with CsA-AZA versus FK506-MPA: Comparison of early outcomes after lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013